ID18010A - MODIFIED OLIGOSAKARIDA - Google Patents

MODIFIED OLIGOSAKARIDA

Info

Publication number
ID18010A
ID18010A IDP972766A ID972766A ID18010A ID 18010 A ID18010 A ID 18010A ID P972766 A IDP972766 A ID P972766A ID 972766 A ID972766 A ID 972766A ID 18010 A ID18010 A ID 18010A
Authority
ID
Indonesia
Prior art keywords
oligosakarida
modified
modified oligosakarida
Prior art date
Application number
IDP972766A
Other languages
Indonesian (id)
Inventor
Gebfard Dr Thoma
Rolf Dr Banteli
Willy Dr Kinzy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID18010A publication Critical patent/ID18010A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
IDP972766A 1996-08-08 1997-08-08 MODIFIED OLIGOSAKARIDA ID18010A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810526 1996-08-08
EP96810527 1996-08-08
EP96810636 1996-09-26

Publications (1)

Publication Number Publication Date
ID18010A true ID18010A (en) 1998-02-19

Family

ID=27237868

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972766A ID18010A (en) 1996-08-08 1997-08-08 MODIFIED OLIGOSAKARIDA

Country Status (19)

Country Link
EP (1) EP0920437A1 (en)
JP (1) JP2000516224A (en)
KR (1) KR20000029862A (en)
CN (1) CN1227563A (en)
AR (1) AR008283A1 (en)
AU (1) AU720381B2 (en)
BR (1) BR9711117A (en)
CA (1) CA2260854A1 (en)
CO (1) CO4900075A1 (en)
CZ (1) CZ39099A3 (en)
ID (1) ID18010A (en)
IL (1) IL127908A0 (en)
NO (1) NO990497L (en)
NZ (1) NZ334048A (en)
PE (1) PE99298A1 (en)
PL (1) PL331286A1 (en)
SK (1) SK15699A3 (en)
TR (1) TR199900245T2 (en)
WO (1) WO1998006730A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
WO2000044367A2 (en) 1999-02-01 2000-08-03 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
WO2004004636A2 (en) * 2002-07-03 2004-01-15 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
ES2334220T3 (en) 2002-10-11 2010-03-08 Astellas Pharma Europe B.V. GLUCOSE-BASED COMPOUNDS WITH AFFINITY FOR P-SELECTIVE.
JP2007524658A (en) * 2003-11-19 2007-08-30 グリコミメティクス, インコーポレイテッド Glucose mimetic antagonists for both E- and P-selectin
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
PL1934236T3 (en) 2005-09-02 2013-04-30 Glycomimetics Inc Heterobifunctional pan-selectin inhibitors
AU2008216794A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-acetyl hexosamines
AU2008336249B2 (en) 2007-12-10 2015-01-29 The University Of Queensland Treatment and prophylaxis
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
WO2013096926A1 (en) 2011-12-22 2013-06-27 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
LT2928476T (en) 2012-12-07 2018-05-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
SI3227310T1 (en) 2014-12-03 2019-11-29 Glycomimetics Inc Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
JP2019524791A (en) 2016-08-08 2019-09-05 グリコミメティクス, インコーポレイテッド Combinations of T cell checkpoint inhibitors with inhibitors of E-selectin or inhibitors of CXCR4 or with heterobifunctional inhibitors of both E-selectin and CXCR4
KR20240046288A (en) 2016-10-07 2024-04-08 글리코미메틱스, 인크. Highly potent multimeric e-selectin antagonists
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
JP7304863B2 (en) 2017-12-29 2023-07-07 グリコミメティクス, インコーポレイテッド Heterobifunctional inhibitors of E-selectin and galectin-3
CN108299525B (en) * 2018-01-05 2021-03-26 佛山科学技术学院 Method for synthesizing Lewis oligose-X
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CN109762032A (en) * 2019-01-16 2019-05-17 天津科技大学 A kind of sulfonated lewis X trisaccharide and its synthetic method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023031A1 (en) * 1992-05-08 1993-11-25 The Biomembrane Institute Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
US5763413A (en) * 1993-03-04 1998-06-09 Mect Corporation Lewis-associated compound, process for producing the same, and anti-inflammatory
SK141695A3 (en) * 1993-05-14 1996-10-02 Cytel Corp Analogous compound sialyl lex, pharmaceutical agent containing this compound and method of preparation of lactoseammoniacal salt
EP0801071A4 (en) * 1994-12-28 1999-01-13 Sumitomo Pharma Lewis x derivative and process for producing the same

Also Published As

Publication number Publication date
SK15699A3 (en) 1999-07-12
WO1998006730A1 (en) 1998-02-19
AR008283A1 (en) 1999-12-29
CA2260854A1 (en) 1998-02-19
NZ334048A (en) 2000-05-26
AU4378897A (en) 1998-03-06
KR20000029862A (en) 2000-05-25
PE99298A1 (en) 1999-01-21
AU720381B2 (en) 2000-06-01
CO4900075A1 (en) 2000-03-27
IL127908A0 (en) 1999-11-30
BR9711117A (en) 1999-09-08
CN1227563A (en) 1999-09-01
PL331286A1 (en) 1999-07-05
NO990497D0 (en) 1999-02-03
JP2000516224A (en) 2000-12-05
TR199900245T2 (en) 1999-05-21
CZ39099A3 (en) 1999-05-12
EP0920437A1 (en) 1999-06-09
NO990497L (en) 1999-03-24

Similar Documents

Publication Publication Date Title
BR9703884A (en) Cycloalkanopyridines
ATE208395T1 (en) THIOPHENOPYRIMIDINES
BR9704464A (en) Eviscerator
ATE262512T1 (en) ARYLALKANOYLPYRIDAZINE
ID18010A (en) MODIFIED OLIGOSAKARIDA
ATE208773T1 (en) QUINOXALINDIONE
FI101456B1 (en) Flercylinderpipett
ATE353652T1 (en) ESTROPROGESTATIVE CONTRACEPTIONAL
BR9703563A (en) Hydromancal
BR9703835A (en) Hydromancal
BR9707467A (en) 1-Pyrazol-3-ylethyl-4-indole-3-ylpiperdins
BR9708716A (en) 3-cyanoaryl-pyrazoles
SE9700055D0 (en) Frösåningsapparat
DE29602607U1 (en) Bitbox
DE29603135U1 (en) Streak-bleaching-coloring-clip
ATE267568T1 (en) EPITHESIS
BR9603698A (en) Dorsum-lumbar hydro-brush
BR7601310U (en) Microbook
BR9603976A (en) Stop-clog
BR9603975A (en) Fix-catch
BR9603887A (en) Fix-imobi
BR9603978A (en) Confort-let
BR9603463A (en) Hydro-collection
BR9604349A (en) Xapisqueira
BR9604479A (en) Gongorremo